John Oliver’s Makes The Case For Psychedelic Assisted Therapy On ‘Last Week Tonight’

February 21, 2023 · The Dales Report

John Oliver is back on “Last Week Tonight” and is once again taking a deep dive into a very intriguing topic: the potential benefits of psychedelic assisted therapy. The show, which aired on Sunday, delves into the history of psychedelics and its potential benefits for mental health.

After classically making fun of himself, Oliver, a self-proclaimed drug connoisseur, goes on to look into the different uses of psychedelics, including spirituality, healing, and recreation, throughout the centuries. However, the show focuses on the use of psychedelics in therapy.

Through interviews with veterans who have suffered from PTSD and have undergone psychedelic assisted therapy, Oliver showcases the positive impact the treatment has had on their lives. One veteran shares how the treatment helped him reconnect with his body and made him feel more comfortable with living. Another veteran who underwent a full dosage of psychedelic treatment claimed a significant reduction in symptoms, with immediate results after his first session.

The show’s tone becomes serious as Oliver warns viewers that psychedelic use has been heavily regulated in the past, with lawmakers and society being fearful of the unknown effects of these drugs. What’s more, the host cautions that we could repeat the same mistakes of the past if we do not proceed carefully in the years ahead.

As Oliver points out, the FDA is expected to approve MDMA and psilocybin for clinical use soon. The potential of these drugs is promising, but there are concerns about accessibility and the need for caution in administering these drugs in a controlled setting with trained medical professionals.

Companies like Compass Pathways CMPS have also sought patents to protect their formulations and methods of administering psychedelic assisted therapy, leading to concerns about affordability and accessibility. (Full Story)

Next Post

Yale digs into the science of cannabis

As many U.S. states adopt policies that legalize the commercialization of cannabis, Yale School of Medicine recently announced the creation of the new Yale Center for the Science of Cannabis and Cannabinoids, which will investigate the acute and chronic effects of cannabis…
Read
Previous Post

Study: Cannabis Has Positive Impact on Sexual Quality

A study published last month in the Journal of Cannabis Research suggests that cannabis use has a positive impact on sexual quality. In the study, an online survey of 811 people, more than 70% of respondents reported increased sexual desire and orgasm…
Read
Random Post

Pay Someone Else to Roll Your Joint, You Bet! - Cannabis Pre-Roll Sales Grow Faster Than Any Other Cannabis Product Categories

Custom Cones USA has joined forces with Headset, a cannabis data company, to release a white paper investigating the popularity of products among their customers. Titled "The State of the Pre-Roll Industry," this comprehensive report delves into various aspects of pre-rolls,…
Read
Random Post

Organigram takes Canadian government to court over cannabis lozenge dispute

Canadian marijuana operator Organigram Holdings is asking a federal court to quash a Health Canada decision that the company’s popular ingestible cannabis lozenges should be classified and regulated as edibles instead of extracts. The legal challenge could have broader implications for Canada’s…
Read
Random Post

First Of Its Kind; Cannabis Dispensary Shares Space With Cafe, Bakery

Some customers tend to go to a cannabis dispensary for hybrid products, but never to a hybrid dispensary space that is shared with a bakery and a liquor-licensed cafe.  Well, this is now the reality for Wheeling’s second cannabis dispensary…
Read
Random Post

DEA Official Says New Rules Are Coming For Synthetic Cannabinoids, Including CBD And Delta-8 THC

The Drug Enforcement Administration (DEA) will soon be proposing new rules to clarify that synthetically manufactured cannabinoids like delta-8 THC are prohibited controlled substances. At the agency’s 2023 Supply Chain Conference earlier this month, Terrance Boos, chief of DEA’s Drug…
Read